The susceptibility of a target cell to killing by NK cells is inversel
y correlated with target cell expression of MHC class I molecules. We
have recently demonstrated that a murine NK cell surface molecule, Ly-
49, is a primary determinant of IL-2-activated NK cell specificity by
apparently acting as an inhibitory receptor. Ly-49 seems to interact w
ith polymorphic regions of certain MHC class I molecules on target cel
ls, yet is expressed only by a subset (15 to 20%) of NK cells. If the
interaction between Ly-49 and MHC class I represents a paradigm for un
derstanding IL-2-activated NK cell specificity and putative inhibitory
IL-2-activated NK cell receptors, these effector cells should express
other molecules, perhaps related to Ly-49, that provide the inhibitor
y receptor function. We now report the isolation of cDNAs, encoding po
lypeptides related to Ly-49, from a CD3(-), IL-2-activated NK cell lib
rary. Full length PCR products were also cloned and sequenced, confirm
ing expression in IL-2-activated NK cells. These cDNAs were homologous
to the Ly-49 cDNA and seem to be derived from distinct genes. The new
cDNAs encode type II integral membrane proteins having lectin superfa
mily homology and 66 to 79% amino acid identity with Ly-49A. In contra
st to previous reports, these cDNAs cannot be allelic variants because
they were all isolated from C57BL/6-derived cells. On the basis of nu
cleotide homology, the cDNAs could be segregated into five groups; one
with Ly-49 itself (now termed Ly-49A) and four others containing dist
inct sequences. One of the new groups comprised three cDNAs that share
d identical sequences, but differed from one another by deletions or i
nsertions of short DNA segments in the predicted extracellular region
of the polypeptides. Thus, IL-2-activated NK cells express mRNAs for m
ultiple, Ly-49-related molecules.